In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 3rd, 2005 | 22 | Yes |
Popular Name: Fenofibric acid Fenofibric acid
Find On: PubMed — Wikipedia — Google
CAS Numbers: 258834-37-6 , 42017-89-0 , 856676-23-8 , [42017-89-0] , [856676-23-8]
2-(4- -2-METHYLPROPANOICACIDSODIUMSALT
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid
2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid sodium salt
2-Hydroxy-N,N,N-trimethylethanaminium 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid
2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic acid
856676-23-8; Choline fenofibrate (USAN/INN); D08890
Fenofibric acid (FDA); Choline Fenofibrate (FDA
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.18 | 1.72 | -50.04 | 0 | 4 | -1 | 66 | 317.748 | 5 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Purity | 95% | Fluorochem |
Purity | 98% | Fluorochem |
Indications | antihypercholesterolemic | KeyOrganics Bioactives |
Therapy | antihyperlipidemic | SMDC Pharmakon |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
FABPI-3-E | Fatty Acid Binding Protein Intestinal (cluster #3 Of 3), Eukaryotic | Eukaryotes | 1000 | 0.38 | Binding ≤ 10μM |
FABPL-3-E | Fatty Acid-binding Protein, Liver (cluster #3 Of 4), Eukaryotic | Eukaryotes | 94 | 0.45 | Binding ≤ 10μM |
PPARA-1-E | Peroxisome Proliferator-activated Receptor Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 4500 | 0.34 | Binding ≤ 10μM |
PPARA-1-E | Peroxisome Proliferator-activated Receptor Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 9200 | 0.32 | Functional ≤ 10μM |
Z81135-4-O | L6 (Skeletal Muscle Myoblast Cells) (cluster #4 Of 4), Other | Other | 3000 | 0.35 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
FABPI_HUMAN | P12104 | Fatty Acid Binding Protein Intestinal, Human | 1000 | 0.38 | Binding ≤ 1μM |
FABPL_RAT | P02692 | Fatty Acid-binding Protein, Liver, Rat | 100 | 0.45 | Binding ≤ 1μM |
FABPI_HUMAN | P12104 | Fatty Acid Binding Protein Intestinal, Human | 1000 | 0.38 | Binding ≤ 10μM |
FABPL_RAT | P02692 | Fatty Acid-binding Protein, Liver, Rat | 100 | 0.45 | Binding ≤ 10μM |
PPARA_HUMAN | Q07869 | Peroxisome Proliferator-activated Receptor Alpha, Human | 2646 | 0.35 | Binding ≤ 10μM |
Z81135 | Z81135 | L6 (Skeletal Muscle Myoblast Cells) | 3000 | 0.35 | Functional ≤ 10μM |
PPARA_HUMAN | Q07869 | Peroxisome Proliferator-activated Receptor Alpha, Human | 9200 | 0.32 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of gene expression by SREBF (SREBP) | |
BMAL1:CLOCK,NPAS2 activates circadian gene expression | |
Circadian Clock | |
Nuclear Receptor transcription pathway | |
PPARA activates gene expression | |
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alp | |
REV-ERBA represses gene expression | |
RORA activates circadian gene expression | |
Transcriptional activation of mitochondrial biogenesis | |
Transcriptional regulation of white adipocyte differentiation | |
YAP1- and WWTR1 (TAZ)-stimulated gene expression |
No pre-computed analogs available. Try a structural similarity search.